Contracts › 75F40124C00131
75F40124C00131: A Mosaic Approach for Understanding Stimulant and Opioid Use and Use Disorder Trajectories and Associated Consequences in Us Adults
Awarded to Regents of the University of Michigan by Food and Drug Administration (FDA).
$1.6Mobligated
$2.2Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00131 |
|---|---|
| Awardee | Regents of the University of Michigan |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | B504 Special Studies/Analysis- Chemical/Biological |
| Place of performance | MI |
| Offers received | 1 |
| Period of performance | 12 September 2024 to 29 September 2027 |
| Potential end | 29 September 2028 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record